Fatty acid profiles of blood lipids from patients with X-linked retinitis pigmentosa (XLRP) supplemented with docosahexaenoic acid (DHA) for four years

被引：0
|
作者：
Hoffman, DR
Locke, KG
Wheaton, DH
Fish, GE
Watkins, RB
Birch, DG
机构：
[1] Retina Fdn SW, Dallas, TX USA
[2] Texas Retina Associates, Dallas, TX USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2002年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2412
引用
收藏
页码：U572 / U572
页数：1
相关论文
共 42 条
  • [11] Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa
    Hoffman, DR
    DeMar, JC
    Heird, WC
    Birch, DG
    Anderson, RE
    JOURNAL OF LIPID RESEARCH, 2001, 42 (09) : 1395 - 1401
  • [12] N-3 fatty acid metabolism in X-linked Retinitis pigmentosa
    McColl, AJ
    Pollacchi, AG
    Converse, CA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 3680 - 3680
  • [13] Safety Assessment of Docosahexaenoic Acid in X-Linked Retinitis Pigmentosa: The 4-Year DHAX Trial
    Hughbanks-Wheaton, Dianna K.
    Birch, David G.
    Fish, Gary E.
    Spencer, Rand
    Pearson, N. Shirlene
    Takacs, Alison
    Hoffman, Dennis R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (08) : 4958 - 4966
  • [14] A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa
    Hoffman, DR
    Locke, KG
    Wheaton, DH
    Fish, GE
    Spencer, R
    Birch, DG
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 137 (04) : 704 - 718
  • [15] Dietary nutrients and yearly rates of decline in retinal function in patients with X-linked retinitis pigmentosa (XLRP)
    Birch, DG
    Locke, KG
    Wheaton, DH
    Fish, GE
    Hoffman, DR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U108 - U108
  • [16] Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial tor X-linked retinitis pigmentosa
    Wheaton, DH
    Hoffman, DR
    Locke, KG
    Watkins, RB
    Birch, DG
    ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (09) : 1269 - 1278
  • [17] Docosahexaenoic Acid Slows Visual Field Progression in X-Linked Retinitis Pigmentosa: Ancillary Outcomes of the DHAX Trial
    Hoffman, Dennis R.
    Hughbanks-Wheaton, Dianna K.
    Spencer, Rand
    Fish, Gary E.
    Pearson, N. Shirlene
    Wang, Yi-Zhong
    Klein, Martin
    Takacs, Alison
    Locke, Kirsten G.
    Birch, David G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (11) : 6646 - 6653
  • [18] Four-Year Placebo-Controlled Trial of Docosahexaenoic Acid in X-Linked Retinitis Pigmentosa (DHAX Trial) A Randomized Clinical Trial
    Hoffman, Dennis R.
    Hughbanks-Wheaton, Dianna K.
    Pearson, N. Shirlene
    Fish, Gary E.
    Spencer, Rand
    Takacs, Alison
    Klein, Martin
    Locke, Kirsten G.
    Birch, David G.
    JAMA OPHTHALMOLOGY, 2014, 132 (07) : 866 - 873
  • [19] The mutation spectrum of RPGR-ORF15 in North American patients with X-linked retinitis pigmentosa (XLRP).
    Rabe, VW
    Sharon, D
    Berson, EL
    Dryja, TP
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S642 - S642
  • [20] The burden of X-linked retinitis pigmentosa (XLRP) on patient experience and patient-reported outcomes (PROs): findings from the EXPLORE XLRP-2 study
    Parmeggiani, Francesco
    Weber, Michel
    Bremond-Gignac, Dominique
    Daly, Avril
    Denee, Tom
    Lahaye, Marjolein
    Lotery, Andrew
    Paudel, Nabin
    Ritter, Markus
    de la Rua, Enrique Rodriguez
    Rotenstreich, Ygal
    Sankila, Eeva-Marja
    Stingl, Katarina
    Van Denderen, Jacqueline
    Pungor, Katalin
    EYE, 2025, 39 (03) : 578 - 585
12345